John Theurer Cancer Center
Cancer Doesn’t Wait and Neither Should You
Don’t let fear get in the way of your care. When it comes to cancer, finding and treating it early gives you the best chance of beating it. Medical experts are taking special precautions to ensure your safety during the pandemic. Hackensack Meridian Health nurses are available by phone or video. Call 551-996-5855 to connect with the care you need.
New Jersey’s Largest, Most Comprehensive
Cancer Care Program
With more than 1,200 team members collaborating in a highly subspecialized and multidisciplinary environment, John Theurer Cancer Center, part of Hackensack University Medical Center, offers one of the most prominent cancer care programs nationwide.
It’s no surprise why more people turn to John Theurer Cancer Center for cancer treatment each year than to any other facility in New Jersey.
With CAR T-cell therapy, immune cells called T cells are:
- Removed from the patient through a process called “apheresis” (the separation of T cells from other components of the blood)
- Genetically modified, using a disarmed virus, to produce receptors on their surfaces called CARs, allowing the T cells to recognize and attach to certain targets on cancer cells
- Grown to larger quantities (hundreds of millions)
- Returned to the patient, where the CAR T cells can now find, bind to, and kill cancer cells
For more information please call 551-996-5931.
Teaming Up to Take on Cancer
John Theurer Cancer Center. Georgetown Lombardi Comprehensive Cancer Center. Two strong institutions that share a passion and expertise for developing new therapies to improve outcomes for patients with cancer.Joining Forces
The largest clinical research team in New Jersey.Research at John Theurer Cancer Center
For More Information
Call us to speak with a member of our team.Call 551-996-5855
You may also be interested in
The Research Division consolidates the basic and translational research and clinical trials that are conducted at John Theurer Cancer Center and the David Joseph Jurist Research Center for Tomorrows Children.
The BMT program, which offers both autologous and donor stem cell transplantations, has consistently been awarded highest grades by FACT accreditation for 25 years.
Our patients have access to tomorrow’s cancer medicines including new agents which can offer successful alternatives to chemotherapy. The depth and breadth of experience of our world class experts, who each focus on specific subtypes of cancer, results in the best available personalized care.